NCT04354649View on ClinicalTrials.gov

Immune-Mediated Pathophysiology And Clinical Triage Program

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2029

Conditions
ArthritisArthralgia
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine 5mg/kg PO daily

OTHER

Placebo

Hydroxychloroquine-matching placebo

Trial Locations (1)

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER